Non-invasive fetal RHD genotyping tests: A systematic review of the quality of reporting of diagnostic accuracy in published studies

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 142, Issue 2, 2009, Pages 91-98

  Freeman, Karoline ^a   Szczepura, Ala ^a   Osipenko, Leeza ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Non invasive prenatal diagnosis; Quality assessment; RhD; Sensitivity and specificity; Test accuracy

Indexed keywords

RHESUS D ANTIGEN;

CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; GENOTYPE; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW;

EID: 59249101943     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.10.010     Document Type: Review

References (43)

1. Lo Y.M.D., Bowell P.J., Selinger M., et al. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet 341 8853 (1993) 1147-1148
2. Geifman-Holtzman O., Bernstein I.M., Berry S.M., et al. Fetal RhD genotyping in fetal cells flow sorted from maternal blood. Am J Obstet Gynecol 174 3 (1996) 818-822
3. Lo Y.M.D., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 (1997) 485-487
4. Siva S.C., Johnson S.I., McCracken S.A., and Morris J.M. Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation. Aust N Z J Obstet Gynaecol 43 1 (2003) 10-15
5. Costa J.-M., Giovangrandi Y., Ernault P., et al. Fetal RhD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 119 (2002) 255-260
6. Legler T., Lynen R., Maas J.H., et al. Prediction of fetal RhD and Rh CcEe phenotype from maternal plasma with real-time PCR. Transfus Apher Sci 27 3 (2002) 217-223
7. Zhong X.Y., Holzgreve W., and Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 107 6 (2000) 766-769
8. Cunningham J., Yates Z., Hamlington J., Mason G., Mueller R., and Miller D. Non-invasive RNA-based determination of fetal Rhesus D type: a prospective study based on 96 pregnancies. BJOG 106 (1999) 1023-1028
9. Finning K.M., Martin P.G., Soothil P.W., and Avent N.D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RhD genotyping service. Transfusion 42 (2002) 1079-1085
10. Chilcott J., Tappenden P., Jones M.L., et al. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. BJOG 111 (2004) 903-907
11. Aubin J.-T., Le Van Kim C., Mouro I., et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 98 (1997) 356-364
12. Daniels G., Finning K., Martin P., and Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 87 (2004) 225-232
13. Machado I.N., Castillo L., Pellegrino Jr. J., and Barini R. Fetal RhD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 52 4 (2006) 232-235
14. Brojer E., Zupanska B., Orzinska A., and Kalinska A. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45 (2005) 1473-1480
15. Gautier E., Benachi A., Giovangrandi Y., et al. Fetal RhD genotyping by maternal serum analysis: a two year experience. Am J Obstet Gynecol 192 (2005) 666-669
16. Finning K.M., Martin P., and Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 1022 (2004) 119-123
17. Van der Schoot E, Bleker O, Bonsel G, Christiaens G, Kanhai H. ZonMw. Final Report Health Care Efficiency Research Programme on http://www.zonmw.nl; 2005.
18. Szczepura A., Osipenko L., and Freeman K. Non-invasive prenatal diagnosis (NIPD): Fetal RHD Genotype: Early-HTA Report. SAFE NoE (2007). http://www.safenoe.org/ Available at: www.safenoe.org
19. Bianchi D.W., Avent N.D., Costa J.-M., and van der Schoot C.E. Noninvasive prenatal diagnosis of fetal Rhesus D. Ready for Primer Time. Obstet Gynecol 106 4 (2005) 841-844
20. Geifman-Holtzman O., Grotegut C.A., and Gaughan J.P. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 195 4 (2006) 1163-1173
21. Bossuyt M.P., Reitsma J.B., Bruns D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 49 1 (2003) 1-6
22. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49 1 (2003) 7-18
23. Zhong X.Y., Holzgreve W., and Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 131 5-6 (2001) 70-74
24. Lo Y.M.D., Hjelm N.M., Fidler C., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339 (1998) 1734-1738
25. Rouillac-Le Sciellour C., Puillandre P., Gillot R., et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 8 1 (2004) 23-31
26. Gonzalez-Gonzalez C., Garcia-Hoyos M., Trujillo-Tiebas M.J., et al. Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience. J Histochem Cytochem 53 3 (2005) 307-314
27. Lo Y.M., Lau T.K., Zhang J., et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45 (1999) 1747-1751
28. Hromadnikova I., Vesela K., Benesova B., et al. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies. Prenat Diagn 25 12 (2005) 1079-1083
29. Bischoff F.Z., Nguyen D.D., Maequez-Do D., Moise Jr. K.J., Simpson J.L., and Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 6 (1999) 64-69
30. Hromadnikova I., Vechetova L., Vesela K., et al. Non-invasive fetal RhD exon 7 and exon 10 genotyping using real-time PDR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 20 4 (2005) 275-280
31. Zhou L., Thorson J.A., Nugent C., Davenport R.D., Butch S.H., and Judd W.J. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 193 6 (2005) 1966-1971
32. Minion J.M., Schaaps J.P., Retz M.C., Dricot J.F., Foidart J.M., and Senterre J.M. Utilisation en routine clinique du genotypage foetal RHD sur plasma maternel: bilan de deux ans d'activite. J Gynecol Obstet Biol Reprod 34 (2005) 448-453
33. Hromadnikova I., Vechetova L., Vesela K., Benesova B., Doucha J., and Vlk R. Non-invasive Fetal RhD and RhCE Genotyping using real-time PCR testing of maternal plasma in RhD negative pregnancies. J Histochem Cytochem 53 3 (2005) 301-305
34. Randen I., Hauge R., Kjeldsen-Kragh J., and Fagerhol M.K. Prenatal genotyping of RHD and SGY using maternal blood. Vox Sang 85 (2003) 300-306
35. Clausen F.B., Krog G.R., Rieneck K., et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 25 11 (2005) 1040-1044
36. Guz K., Brojer E., Zupanska B., Orzinska A., Kalinska A., and Bec J.R. Non-invasive fetal RhD typing and RhD negative pregnant women-preliminary observations. Obs Ginekol Pol 75 (2004) 21-25
37. Nelson M., Eagle C., Langshaw M., Popp H., and Kronenberg H. Genotyping fetal DNA by non-invasive means: extraction from maternal plasma. Vox Sang 80 (2001) 112-116
38. Al-Mufti R., Howard C., Overton T., et al. Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis. Am J Obstet Gynecol 179 1 (1998) 210-214
39. Turner M.J., Martin C.M., and O'Leary J.J. Detection of fetal Rhesus D gene in a whole blood of women booking for routine antenatal care. Eur J Obstet Gynecol Reprod Biol 108 (2003) 29-32
40. Leeflang M, McDonald S, Scholten RJPM, Reitsma H, Rutjes AWS. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: MR000022.Doi: 10.1002/14651858.MR000022.pub2.
41. Moise Jr. K.J. Noninvasive prenatal RhD testing. Am J Obstet Gynecol 195 (2006) e20
42. Roque H. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 194 (2006) 905-906
43. Van der Schoot C.E., Ait Soussan A., Koelewijn J., Bonsel G., Paget-Christiaens L.G.C., and de Haas M. Non-invasive antenatal RHD typing. Transfus Clin Biol 13 (2006) 53-57